Tecnovatica S.A. (WSE: TEC)
Health Care · Biotechnology · PL
zł0.49
-5.77% today · +97.6% 1Y
Tecnovatica S.A. (WSE: TEC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.42M.
Over the last twelve months the share price has gained 97.6%, trading between 0.24 and 0.86.
Tweenvest scores Tecnovatica S.A. across four factors: quality 39/100, value 49/100. Its strongest factor is value.
TEC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.42M
- Revenue (TTM)
- $61.54K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.47
- 52-week high
- zł0.86
- 52-week low
- zł0.24
- Avg volume (3M)
- —
- Shares outstanding
- 35.04M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vectus Biosystems LimitedASX: VBS | $4.54M | AU$0.11 | -4.55% |
| Bharat Immunologicals & Biologicals Corporation LimitedBSE: 524663 | $4.51M | Rs9.91 | +13.52% |
| Predilife S.A.ENXTPA: ALPRE | $4.46M | €1.01 | +18.82% |
| Longeveron Inc.NasdaqCM: LGVN | $4.43M | $1.39 | -43.95% |
| Nymox Pharmaceutical CorporationOTCPK: NYMX.F | $4.41M | $0.04 | +31.25% |
| Azitra, Inc.NYSEAM: AZTR | $4.33M | $0.07 | -44.96% |
| Kane Biotech Inc.TSXV: KNE | $4.33M | CA$0.03 | -16.67% |
| NuCana plcNasdaqCM: NCNA | $4.27M | $0.99 | -9.99% |
Figures last refreshed Oct 18, 2026.